158 related articles for article (PubMed ID: 9204086)
1. Adapalene 0.1% gel has low skin-irritation potential.
Verschoore M; Poncet M; Czernielewski J; Sorba V; Clucas A
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S104-9. PubMed ID: 9204086
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel.
Queille-Roussel C; Poncet M; Mesaros S; Clucas A; Baker M; Soloff AM
Clin Ther; 2001 Feb; 23(2):205-12. PubMed ID: 11293554
[TBL] [Abstract][Full Text] [Related]
3. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients.
Caron D; Sorba V; Kerrouche N; Clucas A
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S110-2. PubMed ID: 9204087
[TBL] [Abstract][Full Text] [Related]
4. Skin tolerance of adapalene 0.1% gel in combination with other topical antiacne treatments.
Caron D; Sorba V; Clucas A; Verschoore M
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S113-5. PubMed ID: 9204088
[TBL] [Abstract][Full Text] [Related]
5. Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients.
Clucas A; Verschoore M; Sorba V; Poncet M; Baker M; Czernielewski J
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S116-8. PubMed ID: 9204089
[TBL] [Abstract][Full Text] [Related]
6. Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference.
Dunlap FE; Mills OH; Tuley MR; Baker MD; Plott RT
Br J Dermatol; 1998 Oct; 139 Suppl 52():17-22. PubMed ID: 9990416
[TBL] [Abstract][Full Text] [Related]
7. Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations.
Galvin SA; Gilbert R; Baker M; Guibal F; Tuley MR
Br J Dermatol; 1998 Oct; 139 Suppl 52():34-40. PubMed ID: 9990419
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].
Alirezai M; Meynadier J; Jablonska S; Czernielewski J; Verschoore M
Ann Dermatol Venereol; 1996; 123(3):165-70. PubMed ID: 8761775
[TBL] [Abstract][Full Text] [Related]
9. Cumulative irritation potential of topical retinoid formulations.
Leyden JJ; Grossman R; Nighland M
J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s14-8. PubMed ID: 18724650
[TBL] [Abstract][Full Text] [Related]
10. A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China.
Tu P; Li GQ; Zhu XJ; Zheng J; Wong WZ
J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():31-6. PubMed ID: 11843231
[TBL] [Abstract][Full Text] [Related]
11. Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris.
Ellis CN; Millikan LE; Smith EB; Chalker DM; Swinyer LJ; Katz IH; Berger RS; Mills OH; Baker M; Verschoore M; Loesche C
Br J Dermatol; 1998 Oct; 139 Suppl 52():41-7. PubMed ID: 9990420
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.
Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart T; Swinyer L; Whitmore C; Baker M; Czernielewski J
J Am Acad Dermatol; 1996 Mar; 34(3):482-5. PubMed ID: 8609263
[TBL] [Abstract][Full Text] [Related]
13. Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations.
Greenspan A; Loesche C; Vendetti N; Georgeian K; Gilbert R; Poncet M; Baker MD; Soto P
Cutis; 2003 Jul; 72(1):76-81. PubMed ID: 12889719
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris.
Verschoore M; Langner A; Wolska H; Jablonska S; Czernielewski J; Schaefer H
Br J Dermatol; 1991 Apr; 124(4):368-71. PubMed ID: 1827344
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials.
Cunliffe WJ; Caputo R; Dreno B; Förström L; Heenen M; Orfanos CE; Privat Y; Robledo Aguilar A; Meynadier J; Alirezai M; Jablonska S; Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart JM; Swinyer L; Whitmore C; Czernielewski J; Verschoore M
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S126-34. PubMed ID: 9204091
[TBL] [Abstract][Full Text] [Related]
16. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
Ioannides D; Rigopoulos D; Katsambas A
Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
[TBL] [Abstract][Full Text] [Related]
17. Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins.
Goh CL; Tang MB; Briantais P; Kaoukhov A; Soto P
J Dermatolog Treat; 2009; 20(5):282-8. PubMed ID: 19634042
[TBL] [Abstract][Full Text] [Related]
18. Spotlight on adapalene in acne vulgaris.
Waugh J; Noble S; Scott LJ
Am J Clin Dermatol; 2004; 5(5):369-71. PubMed ID: 15554742
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV).
Tirado-Sánchez A; Espíndola YS; Ponce-Olivera RM; Bonifaz A
J Cosmet Dermatol; 2013 Jun; 12(2):103-7. PubMed ID: 23725303
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials.
Cunliffe WJ; Poncet M; Loesche C; Verschoore M
Br J Dermatol; 1998 Oct; 139 Suppl 52():48-56. PubMed ID: 9990421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
